SCF, IL-1β, IL-1ra and GM-CSF in the bone marrow and serum of normal individuals and of AML and CML in patients

Cytokine

Volumn 12, Issue 6, 2000, Pages 699-707

  Tao, Min ^a   Li, Biaoru ^a   Nayini, Jaya ^a   Andrews, Colleen B ^a   Huang, Ray Win ^a   Devemy, Emmanuelle ^a   Song, Shiwen ^a   Venugopal, Parameswaran ^a   Preisler, Harvey D ^a  

^a RUSH CANCER INSTITUTE   (United States)

Author keywords

Leukemia; Marrow cytokines; Serum cytokines

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; STEM CELL FACTOR; IL1RN PROTEIN, HUMAN; INTERLEUKIN 1; SIALOGLYCOPROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BLOOD LEVEL; BONE MARROW; BONE MARROW BIOPSY; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; TISSUE LEVEL; BIOPSY; BLOOD; BONE MARROW CELL; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; REFERENCE VALUE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BIOPSY; BONE MARROW CELLS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID, CHRONIC; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIALOGLYCOPROTEINS; STEM CELL FACTOR; TRANSCRIPTION, GENETIC;

EID: 0033625335     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2000.0666     Document Type: Article

References (33)

1. Griffin JD, Lowenberg B. Clonogenic cells in acute myeloblastic leukemia. Blood. 68:1986;1185-1195.
2. Russell N. Autocrine growth factors and leukemic haemopoiesis. Blood Rev. 6:1992;149-156.
3. Bradbury D, Rogers S, Kozlowski R, Bowen G, Reilly IAG, Russell NH. Interleukin-1 is one factor which regulates autocrine production of GM-CSF by the blast cells of acute myeloblastic leukaemia. Br J Haematol. 76:1990;488-493.
4. Gao X-Z, Bi S, Copra H, Devemy E, Venugopal P, Li B, Hsu W, Loew J, Galvez A, Gregory S, Yang J, Horvath E, Preisler HD. Cytokine gene activity in AML cells in vivo in patients. Leuk Res. 22:1998;429-438.
5. Kaufman DC, Baer MR, Gao X-Z, Wang Z, Preisler HD. Enhanced expression of the granulocyte-macrophage colony stimulating factor gene in acute myelocytic leukemia cells following in-vitro blast cell enrichment. Blood. 72:1988;1329-1332.
6. Baer MR, Watt CC, Preisler HD. Expression of the GM-CSF and IL-1 genes in acute myelogenous leukemia cells is induced by in vitro cell processing. Blood. 72:1998;A109.
7. Rambaldi A, Torcia M, Bettoni S, Vannier E, Barbui T, Shaw AR, Dinarello CA, Cozzolino F. Modulation of cell proliferation and cytokine production in acute myeloblastic leukemia by interleukin-1 receptor antagonist and lack of its expression by leukemic cells. Blood. 78:1991;3248-3253.
8. Sensebe L, Mortenson BT, Fix P, Herve P, Charbord P. Cytokine active on granulomonopoiesis: release and consumption by human marrow myeloid stromal cells. Br J Haematol. 98:1997;274-282.
9. Kovach NL, Lin N, Yednock T, Harlan JM, Broudy VC. Stem cell factor modulates avidity of α4β1 and α5β1 integrins expressed on hemopoietic cell lines. Blood. 85:1995;159-167.
10. Roecklein BA, Torok-Storb B. Functionally distinct human marrow stromal cell lines immotalized by transduction with the human papilloma virus E6/E7 genes. Blood. 85:1995;997-1005.
11. Ramenghi U, Ruggieni L, Dianzani I, Ross C, Brizzi MF, Camaschella C, Pietsch T, Saglio G. Human peripheral blood granulocytes and myeloid leukemic cell lines express both transcripts encoding for stem cell factor. Stem Cells. 12:1994;521-526.
12. Rogers SY, Bradbury D, Kozlowski R, Russell NH. Evidence for internal autocrine regulation of growth in acute myeloblastic cells. Exp Hematol. 22:1994;593-598.
13. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Coates J, Minden M, Patersos E, Caligiurl MA, Dick J. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 367:1994;645-648.
14. Young DC, Griffin JD. Autocrine secretion of GM-CSF in acute myeloblastic leukemia. Blood. 68:1986;1178-1181.
15. Bradbury D, Bowen G, Kozlowski R, Reilly I, Russell N. Endogenous interleukin-1 can regulate the autonomous growth of the blast cells of acute myeloblastic leukemia by inducing autocrine secretion of GM-CSF. Leukemia. 4:1990;44-47.
16. Delwel R, van Buitenen C, Salem M, Bot F, Gillis S, Kaushansky K, Altrock B, Lowenberg B. Interleukin-1 stimulates proliferation of acute myeloblastic leukemia cells by induction of granulocyte-macrophage colony-stimulating factor release. Blood. 74:1989;586-593.
17. Preisler HD, Venugopal P. Regrowth resistance in leukemia and lymphoma: the need for a new system to classify treatment failure and for new approaches to treatment. Leuk Res. 18:1994;149-160.
18. Raza A, Preisler HD, Day R, Yasin Z, White M, Lykins J, Kukla C, Barcos M, Bennett J, Browman G, Goldberg J, Grunwald H, Larson R, Vardiman J, Vogler R. Direct relationship between remission duration in acute myeloid leukemia and cell cycle kinetics: a leukemia intergroup study. Blood. 76:1990;2191-2197.
19. Preisler HD, Raza A, Baccarani M. Proliferative advantage rather than classical drug resistance as the cause of treatment failure in chronic myelogenous leukemia. Leuk Lymphoma. 11:1993;303-306.
20. Preisler HD, Raza A, Larson RA. Alteration of the proliferative rate of acute myelogenous leukemia cells in vivo in patients. Blood. 80:1992;2600-2603.
21. Handa H, Hegde UP, Kotelnikov VM, Mundle SD, Dong LM, Burke P, Rose S, Hsu WT, Gaskin F, Raza A, Preisler HD. The effects of 13-cis retinoic acid and interferon-alpha in chronic leukemia cells in vivo in patients. Leuk Res. 21:1997;1087-1096.
22. Preisler HD, Gao X-Z, Bi S, Devemy E, Loew J, Raza A. Cytokine production and the secondary hematologic disorder. Leuk Lymphoma. 1999.
23. Preisler HD. Fitness landscapes and the myeloid leukemias. Leuk Res. 23:1999;167-176.
24. Cluitmans FHM, Esendam BHJ, Landegent JE, Willimze R, Falkenburg JHF. Constitutive in vivo cytokine and hemopoietic growth factor gene expression in the bone marrow and peripheral blood of healthy individuals. Blood. 85:1995;2038-2044.
25. Sasaki K, Ikeda K, Ogami K, Takahara J, Irino S. Cell-to-cell interaction of cytokine-dependent myeloblastic line constitutively expressing membrane-bound stem cell factor abrogates cytokine dependency partially through granulocyte-macrophage colony stimulating factor production. Blood. 85:1995;1220-1228.
26. Agarwal R, Doren S, Hicks B, Dunbar CE. Long-term culture of chronic myelogenous leukemia marrow cells on stem cell factor-deficient stroma favors benign progenitors. Blood. 85:1995;1306-1312.
27. Wetzler M, Kurzrock R, Estrov Z, Kantarjian H, Gisslinger H, Underbrink MP, Talpaz M. Altered levels of interleukin-1â and interleukin-1a receptor antagonist in chronic myelogenous leukemia: clinic and prognostic correlates. Blood. 84:1994;3142-3147.
28. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood. 77:1991;1627-1652.
29. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood. 87:1996;2095-2147.
30. Gueniche A, Viac J, Lizard G, Charveron M, Schmitt D. Effect of nickel on the activation state of normal human keratinocytes through interleukin-1 and intercellular adhesion molecule 1 expression. Br J Dermatol. 131:1994;250-256.
31. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
32. Bi S, Hughes T, Bungey J, Chase A, de Fabritis P, Goldman JM. p53 in chronic myeloid leukemia cell lines. Leukemia. 6:1992;839-842.
33. Edwards MC, Gibbs RA. Multiplex PCR advantages, development and applications. Genome Research. 3:1994;S65-S75.